Overview
- Multiple reports published May 29, 2026 put the Kremlin’s New Health Preservation Technologies programme under the spotlight and detailed its $26 billion budget and state support.
- Officials and state researchers say the initiative prioritises gene therapy to slow cellular ageing, 3D bioprinting of tissues, xenotransplantation using specially bred mini‑pigs, and extreme cryotherapy.
- The programme cites early milestones such as bioprinted human cartilage and a functioning mouse thyroid gland, but those results lack broad peer‑reviewed publication or independent verification.
- Leadership ties to Putin are reported, with his daughter Maria Vorontsova and Kurchatov Institute chief Mikhail Kovalchuk described as central figures shaping priorities and timelines.
- Internal projections claim the effort could save up to 175,000 lives by 2030, a figure not independently confirmed, and experts warn sanctions and isolation limit outside validation and collaboration.